| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3398057 | Clinical Microbiology and Infection | 2009 | 12 Pages |
Abstract
This review addresses selected aspects of the management of severe healthcare-associated infections due to methicillin-resistant Staphylococcus aureus (MRSA), including the limitations of current therapy, potential alternative agents, new therapeutic options, clinical approaches to MRSA bacteraemia/endocarditis and ventilator-associated pneumonia, and strategies to improve outcomes in patients with severe MRSA infections.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
J. Garau, E. Bouza, J. Chastre, F. Gudiol, S. Harbarth,